All Patents

Technical Background
Biological repair and regeneration mechanisms rely primarily on the regulation and signaling functions of proteins and peptides. Peptides and proteins have been extensively studied worldwide for their potential in tissue repair and regenerative applications.

However, due to their inherent molecular instability, peptides are highly susceptible to hydrolysis and environmental degradation. During manufacturing, storage, and clinical use, loss of bioactivity often occurs, making it challenging to achieve stable mass production and consistent clinical performance.

Accordingly, a critical technological challenge lies in preserving biological activity while enabling stable storage and controlled, effective release of peptide-based compounds.


 









Core Technology Principle
Through a proprietary patented process, JoyCom Group utilizes polysaccharides to construct a multi-layer microencapsulation structure that:


Effectively protects against hydrolysis and environmental interference
Enhances the storage stability of active components
Preserves biological activity during clinical application
Strengthens the sustained functional performance of active ingredients within damaged tissues







This microencapsulation technology not only addresses the stability challenges associated with peptides, but also enables a synergistic interaction between oligopeptides and polysaccharides, further optimizing tissue repair performance.


Clinical Applications
This technology has been extensively applied across multiple clinical settings, including :


Various surgical wounds
Post-cesarean section incisions
Burns and scald injuries
Skin graft procedures
Chronic wounds such as diabetic ulcers and pressure sores
Acute and chronic non-healing wounds

It has been adopted and recognized by numerous medical institutions, demonstrating strong market acceptance within the active wound dressing segment and achieving a leading position in specific postoperative applications.

Built upon this technology, the framework can be further extended to broader tissue repair and bioactivity-preservation applications, delivering more stable and clinically meaningful solutions to the global healthcare market.

Technical Background
Women’s intimate health is closely associated with microbiome balance. Conventional antibiotics and broad-spectrum antimicrobial agents typically employ non-selective mechanisms of action. While they may provide short-term symptom relief, they can disrupt beneficial microbial flora, leading to dysbiosis and an increased risk of recurrent infections.

Accordingly, a critical technological challenge lies in selectively inhibiting pathogenic microorganisms while preserving and supporting the stability of the native lactobacillus-dominant microbiota.

 


             


Core Technology Principle
This patented ingredient is derived from metabolites secreted by natural lactic acid bacteria and is rich in naturally occurring lactic acid, probiotic-derived polysaccharides, and antimicrobial peptides.

Rather than employing an aggressive sterilization approach, its design is based on a selective modulation mechanism, supporting and maintaining intimate health without disrupting the native biological environment.
 



The patented ingredient can be flexibly formulated according to product positioning and regulatory classification, with adjustable composition ratios and dosage forms. It is currently applied in both medical device and daily personal care products, with strong potential for further expansion into diversified intimate care product lines.

Technical Background
A healthy skin structure and an intact barrier function are essential for maintaining hydration and protecting against external irritants and microbial invasion. However, conventional surfactants commonly used in cleansing products—such as SLS (Sodium Lauryl Sulfate) and SLES (Sodium Laureth Sulfate)—are small-molecule agents with strong degreasing properties. Prolonged use may disrupt the stratum corneum and lipid film, leading to dryness, sensitivity, and compromised barrier integrity.

This patented technology was therefore developed to achieve a balanced approach—delivering gentle cleansing performance while preserving skin barrier protection.
 


                              


Core Technology Principle
This patented technology utilizes oligosaccharides and plant-derived oils, processed through a proprietary enzymatic manufacturing method to form a structurally stable, high-molecular-weight saccharide complex. It represents a next-generation protective surfactant (emulsifier) designed with the following principles:


Gently removes surface sebum and impurities
Minimizes disruption to the stratum corneum and lipid barrier
Helps maintain skin barrier integrity
Enhances post-use comfort and hydration







Compared with conventional low-molecular-weight surfactants, this patented molecule features a larger molecular structure, reducing penetration potential and irritation risk. It enables effective cleansing and skincare performance while preserving essential lipids and moisture, making it particularly suitable for formulations that require enhanced mildness and long-term safety.



Patented Features


Protective Surfactant Technology: Cleanses effectively without compromising the integrity of the skin barrier.
Patented Colloidal Structure: Provides sebum adsorption while maintaining skin suppleness and hydration.
High-Safety Ingredients: A patented formulation composed of food-grade components, suitable for product designs with stringent safety requirements.



Applications


Gentle facial cleansing products
Intimate cleansing formulations
Sensitive skin care solutions
Functional skincare base formulations


Formulations and dosage forms can be customized according to product positioning, supporting diverse market requirements and product development strategies.